OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors
Xiaoying Gu, Siyuan Wang, Wanying Zhang, et al.
EBioMedicine (2023) Vol. 98, pp. 104851-104851
Open Access | Times Cited: 37
Xiaoying Gu, Siyuan Wang, Wanying Zhang, et al.
EBioMedicine (2023) Vol. 98, pp. 104851-104851
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 106
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 106
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
Wenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. 845-855
Open Access | Times Cited: 62
Wenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. 845-855
Open Access | Times Cited: 62
Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies
Sarah J. Annesley, Daniel Missailidis, Benjamin Heng, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 443-458
Open Access | Times Cited: 14
Sarah J. Annesley, Daniel Missailidis, Benjamin Heng, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 443-458
Open Access | Times Cited: 14
Systems analysis of innate and adaptive immunity in Long COVID
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich, et al.
Seminars in Immunology (2024) Vol. 72, pp. 101873-101873
Closed Access | Times Cited: 14
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich, et al.
Seminars in Immunology (2024) Vol. 72, pp. 101873-101873
Closed Access | Times Cited: 14
Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis
Juan Jiang, Yantong Li, Qiaoling Jiang, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106190-106190
Closed Access | Times Cited: 10
Juan Jiang, Yantong Li, Qiaoling Jiang, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106190-106190
Closed Access | Times Cited: 10
Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants
Shijie Qin, Yanan Zhang, Yanhua Li, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 52, pp. 101218-101218
Open Access | Times Cited: 8
Shijie Qin, Yanan Zhang, Yanhua Li, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 52, pp. 101218-101218
Open Access | Times Cited: 8
Multi‐Omics Analysis by Machine Learning Identified Lysophosphatidic Acid as a Biomarker and Therapeutic Target for Porcine Reproductive and Respiratory Syndrome
Hao Zhang, Fangyu Hu, Ouyang Peng, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Hao Zhang, Fangyu Hu, Ouyang Peng, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
J Zhang
Heliyon (2024) Vol. 10, Iss. 14, pp. e34577-e34577
Open Access | Times Cited: 4
J Zhang
Heliyon (2024) Vol. 10, Iss. 14, pp. e34577-e34577
Open Access | Times Cited: 4
Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID‐19 Infection
Zhiyong Hou, Yu Ming, Jun Liu, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 1
Open Access
Zhiyong Hou, Yu Ming, Jun Liu, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 1
Open Access
Exploring DNA methylation, telomere length, mitochondrial DNA, and immune function in patients with Long-COVID
Andrea Polli, Lode Godderis, Dries S. Martens, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Andrea Polli, Lode Godderis, Dries S. Martens, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Long COVID: current research and future directions
Rongling Zhang, Xiaoying Gu, Hui Zhang, et al.
Infectious Diseases & Immunity (2025)
Open Access
Rongling Zhang, Xiaoying Gu, Hui Zhang, et al.
Infectious Diseases & Immunity (2025)
Open Access
Longitudinal multi-omics analysis of convalescent individuals with respiratory sequelae 6–36 months after COVID-19
Huqin Yang, Lujia Guan, Yi Xue, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Huqin Yang, Lujia Guan, Yi Xue, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Proteomic Analysis of 442 Clinical Plasma Samples From Individuals With Symptom Records Revealed Subtypes of Convalescent Patients Who Had COVID‐19
Jiang‐Feng Liu, Li Guo, Jingchuan Zhong, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Open Access
Jiang‐Feng Liu, Li Guo, Jingchuan Zhong, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Open Access
The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness
Mecaila E. McClune, Osamudiamen Ebohon, Jules M. Dressler, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 795
Closed Access
Mecaila E. McClune, Osamudiamen Ebohon, Jules M. Dressler, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 795
Closed Access
Proteoform Analysis of the Human Olfactory System: A Window into Neurodegenerative Diseases
Eqrem Rusi, Fiorenza Pennacchia, Wael Abu Ruqa, et al.
Proteomes (2024) Vol. 12, Iss. 1, pp. 9-9
Open Access | Times Cited: 3
Eqrem Rusi, Fiorenza Pennacchia, Wael Abu Ruqa, et al.
Proteomes (2024) Vol. 12, Iss. 1, pp. 9-9
Open Access | Times Cited: 3
Oxidative Stress is a shared characteristic of ME/CFS and Long COVID
Vishnu Shankar, Julie Wilhelmy, Ellis J. Curtis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Vishnu Shankar, Julie Wilhelmy, Ellis J. Curtis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
Timo Schmitz, Dennis Freuer, Yvonne Goßlau, et al.
Virus Research (2024) Vol. 344, pp. 199363-199363
Open Access | Times Cited: 2
Timo Schmitz, Dennis Freuer, Yvonne Goßlau, et al.
Virus Research (2024) Vol. 344, pp. 199363-199363
Open Access | Times Cited: 2
Evaluation of disease severity and prediction of severe cases in children hospitalized with influenza A (H1N1) infection during the post-COVID-19 era: a multicenter retrospective study
Haifeng Liu, Xiao-Zhong Hu, Rongwei Huang, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Haifeng Liu, Xiao-Zhong Hu, Rongwei Huang, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Unravelling long COVID: insights from proteomics and considerations for comprehensive understanding
Chengliang Yang, Casey P. Shannon, Scott J. Tebbutt
EBioMedicine (2024) Vol. 101, pp. 105023-105023
Open Access | Times Cited: 1
Chengliang Yang, Casey P. Shannon, Scott J. Tebbutt
EBioMedicine (2024) Vol. 101, pp. 105023-105023
Open Access | Times Cited: 1
Spatial transcriptomics unveils the in situ cellular and molecular hallmarks of the lung in fatal COVID-19
Carlos A. García‐Prieto, Eva Musulén, Verónica Dávalos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Carlos A. García‐Prieto, Eva Musulén, Verónica Dávalos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19
Sarah E. Holton, Mallorie Mitchem, Hamid Chalian, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0285638-e0285638
Open Access | Times Cited: 1
Sarah E. Holton, Mallorie Mitchem, Hamid Chalian, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0285638-e0285638
Open Access | Times Cited: 1
Longitudinal Assessment of Nasopharyngeal Biomarkers Post-COVID-19: Unveiling Persistent Markers and Severity Correlations
Francisco Javier Redondo Calvo, Yoana Rabanal‐Ruiz, Gema Verdugo-Moreno, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 11, pp. 5064-5084
Open Access | Times Cited: 1
Francisco Javier Redondo Calvo, Yoana Rabanal‐Ruiz, Gema Verdugo-Moreno, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 11, pp. 5064-5084
Open Access | Times Cited: 1
Long COVID elevated MMP-9 and release from microglia by SARS-CoV-2 Spike protein
Duraisamy Kempuraj, Irene Tsilioni, Kristina Aenlle, et al.
Translational Neuroscience (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Duraisamy Kempuraj, Irene Tsilioni, Kristina Aenlle, et al.
Translational Neuroscience (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Targeting G9a translational mechanism of SARS-CoV-2 pathogenesis for multifaceted therapeutics of COVID-19 and its sequalae
Adil Muneer, Ling Xie, Xuping Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Adil Muneer, Ling Xie, Xuping Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Analysis of Prognostic Factors and Establishment of a Nomogram to Predict Risk for COVID-19 Convalescent Patients Based on Metabolomic and Lipidomic
Anzhu Wang, Yingying Yang, Peng Miao, et al.
Research Square (Research Square) (2024)
Open Access
Anzhu Wang, Yingying Yang, Peng Miao, et al.
Research Square (Research Square) (2024)
Open Access
